LANTHEUS HOLDINGS INC (LNTH)

US5165441032 - Common Stock

89.285  -2.66 (-2.89%)

After market: 89.285 0 (0%)

News Image
2 days ago - Chartmill

For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.

While growth is established for LANTHEUS HOLDINGS INC (NASDAQ:LNTH), the stock's valuation remains reasonable.

News Image
10 days ago - Chartmill

Why NASDAQ:LNTH Is a Promising High-Growth Stock in the Midst of Consolidation.

Is LANTHEUS HOLDINGS INC (NASDAQ:LNTH) on the Verge of a Major Breakout as a Strong Growth Stock?

News Image
19 days ago - Market News Video

LNTH Crosses Below Key Moving Average Level

News Image
a month ago - Lantheus Holdings, Inc.

Lantheus Announces Share Repurchase Program

News Image
a month ago - Lantheus Holdings, Inc.

Lantheus Announces Share Repurchase Program

BEDFORD, Mass., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (Lantheus or the Company) (NASDAQ: LNTH), the leading...

News Image
a month ago - Lantheus Holdings, Inc.

Lantheus to Present at the Jefferies London Healthcare Conference

BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...

News Image
a month ago - Lantheus Holdings, Inc.

Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025

BEDFORD, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading...

News Image
2 months ago - Market News Video

Oversold Conditions For Lantheus Holdings (LNTH)

News Image
2 months ago - Lantheus Holdings, Inc.

Lantheus Reports Third Quarter 2024 Financial Results

News Image
2 months ago - Lantheus Holdings, Inc.

Lantheus Reports Third Quarter 2024 Financial Results

Worldwide revenue of $378.7 million, an increase of 18.4% from third quarter 2023GAAP fully diluted earnings per share of $1.79, compared to $1.88 in the...

News Image
2 months ago - Lantheus Holdings, Inc.

Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care

BEDFORD, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...

News Image
2 months ago - Lantheus Holdings, Inc.

Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time

BEDFORD, Mass., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH) today announced that it will host a conference...

News Image
3 months ago - USA News Group

Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players

/PRNewswire/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years....

News Image
3 months ago - USA News Group

Cancer Research Sees Major Boost as New Breakthroughs Emerge from Key Oncology Players

/CNW/ -- USA News Group – In the oncology world, there's been plenty to celebrate recently, with cancer deaths falling by 33% in the last 30 years. However,...

News Image
3 months ago - Lantheus Holdings, Inc.

Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024

Study met its primary endpoint, demonstrating significant improvement in radiographic progression-free survival Overall Response Rate was 38.1% vs. 12.0%...

News Image
4 months ago - Lantheus Holdings, Inc.

Lantheus Appoints Julie Eastland as New Board Member

BEDFORD, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company...